← Back to Healthcare

Drug Manufacturers - Specialty & Generic

Industry Overview

Stock Screener

Select filters to narrow down the 163 companies below

163 companies
$0B >$1T

Ratio between share price and earnings per share. A low ratio could indicate undervaluation.

<0 >50

Ratio of dividends in the last 12 months to current share price.

0% 3%

Revenue increase compared to the same quarter one year ago.

0% 30%

Net income increase compared to the same quarter one year ago.

0% 30%

Profitability of the last quarter.

<-30% >30%

A higher ratio indicates a higher risk. The ratio is difficult to compare between industries.

<0 >3

Discounted cash flow valuation vs. current price. Positive = undervalued, negative = overvalued.

<-50% >+100%
Market Cap $36.48B
Dividends 1.2%
P/E Ratio 39.5
Revenue $4.64B -4.0%
Net Income $425M -412.5%
Profit Margin +9.2%
Employees 22.05K
View Stock
Market Cap $29.76B
Dividends 5.7%
P/E Ratio -37.1
Revenue $3.08M -43.2%
Net Income -$25.9M +570.7%
Profit Margin -842.9%
Employees 62
View Stock
Market Cap $29.76B
Dividends 4.5%
P/E Ratio
Revenue $3.08M -43.2%
Net Income -$25.9M +570.7%
Profit Margin -842.9%
Employees 62
View Stock
Market Cap $29.76B
Dividends 12.6%
P/E Ratio
Revenue $3.08M -43.2%
Net Income -$25.9M +570.7%
Profit Margin -842.9%
Employees 62
View Stock
Market Cap $29.76B
Dividends 4.7%
P/E Ratio
Revenue $3.08M -43.2%
Net Income -$25.9M +570.7%
Profit Margin -842.9%
Employees 62
View Stock
Market Cap $29.76B
Dividends 3.7%
P/E Ratio
Revenue $3.08M -43.2%
Net Income -$25.9M +570.7%
Profit Margin -842.9%
Employees 62
View Stock
Market Cap $29.76B
Dividends 3.5%
P/E Ratio
Revenue $3.08M -43.2%
Net Income -$25.9M +570.7%
Profit Margin -842.9%
Employees 62
View Stock
Market Cap $29.76B
Dividends 4.2%
P/E Ratio
Revenue $3.08M -43.2%
Net Income -$25.9M +570.7%
Profit Margin -842.9%
Employees 62
View Stock
Market Cap $29.76B
Dividends 7.9%
P/E Ratio
Revenue $3.08M -43.2%
Net Income -$25.9M +570.7%
Profit Margin -842.9%
Employees 62
View Stock
Market Cap $29.76B
Dividends 6.8%
P/E Ratio
Revenue $3.08M -43.2%
Net Income -$25.9M +570.7%
Profit Margin -842.9%
Employees 62
View Stock
Market Cap $29.76B
Dividends
P/E Ratio
Revenue $3.08M -43.2%
Net Income -$25.9M +570.7%
Profit Margin -842.9%
Employees 62
View Stock
Market Cap $29.76B
Dividends 1.7%
P/E Ratio
Revenue $3.08M -43.2%
Net Income -$25.9M +570.7%
Profit Margin -842.9%
Employees 62
View Stock
Market Cap $29.76B
Dividends 1.4%
P/E Ratio
Revenue $3.08M -43.2%
Net Income -$25.9M +570.7%
Profit Margin -842.9%
Employees 62
View Stock
Market Cap $29.76B
Dividends 2.2%
P/E Ratio
Revenue $3.08M -43.2%
Net Income -$25.9M +570.7%
Profit Margin -842.9%
Employees 62
View Stock
Market Cap $29.76B
Dividends 5.2%
P/E Ratio
Revenue $3.08M -43.2%
Net Income -$25.9M +570.7%
Profit Margin -842.9%
Employees 62
View Stock
Market Cap $29.76B
Dividends 2.8%
P/E Ratio
Revenue $3.08M -43.2%
Net Income -$25.9M +570.7%
Profit Margin -842.9%
Employees 62
View Stock
Market Cap $29.76B
Dividends 5.8%
P/E Ratio
Revenue $3.08M -43.2%
Net Income -$25.9M +570.7%
Profit Margin -842.9%
Employees 62
View Stock
Market Cap $29.76B
Dividends 0.6%
P/E Ratio
Revenue $3.08M -43.2%
Net Income -$25.9M +570.7%
Profit Margin -842.9%
Employees 62
View Stock
Market Cap $29.76B
Dividends 3.4%
P/E Ratio
Revenue $3.08M -43.2%
Net Income -$25.9M +570.7%
Profit Margin -842.9%
Employees 62
View Stock
Market Cap $29.76B
Dividends 0.1%
P/E Ratio
Revenue $3.08M -43.2%
Net Income -$25.9M +570.7%
Profit Margin -842.9%
Employees 62
View Stock